The different effector function capabilities of the seven equine IgG subclasses have implications for vaccine strategies.
about
Retinal glycoprotein enrichment by concanavalin a enabled identification of novel membrane autoantigen synaptotagmin-1 in equine recurrent uveitisGastrointestinal helminths may affect host susceptibility to anthrax through seasonal immune trade-offs.A fully caninised anti-NGF monoclonal antibody for pain relief in dogsImmunogenicity of an electron beam inactivated Rhodococcus equi vaccine in neonatal foals.Polymeric human Fc-fusion proteins with modified effector functions.Oral Administration of Electron-Beam Inactivated Rhodococcus equi Failed to Protect Foals against Intrabronchial Infection with Live, Virulent R. equiNovel IgG-Degrading Enzymes of the IgdE Protease Family Link Substrate Specificity to Host Tropism of Streptococcus SpeciesApplied Protein and Molecular Techniques for Characterization of B Cell Neoplasms in Horses.Magnetic Nanovectors for the Development of DNA Blood-Stage Malaria Vaccines.Review of equine piroplasmosis.Immune responses to ectoparasites of horses, with a focus on insect bite hypersensitivity.The development of equine immunity: Current knowledge on immunology in the young horse.Challenges in Veterinary Vaccine Development and Immunization.A common theme in interaction of bacterial immunoglobulin-binding proteins with immunoglobulins illustrated in the equine system.Immunological correlates of vaccination and infection for equine herpesvirus 1.Equine arteritis virus elicits a mucosal antibody response in the reproductive tract of persistently infected stallions.Protective effects of passively transferred merozoite-specific antibodies against Theileria equi in horses with severe combined immunodeficiency.Histidine-rich designer peptides of the LAH4 family promote cell delivery of a multitude of cargo.In Vitro and In Vivo Characterization of a Fully Felinized Therapeutic Anti-Nerve Growth Factor Monoclonal Antibody for the Treatment of Pain in Cats.IgA in the horse: cloning of equine polymeric Ig receptor and J chain and characterization of recombinant forms of equine IgA.IgG subclass co-expression brings harmony to the quartet model of murine IgG function.Immune parameters to p67C antigen adjuvanted with ISA206VG correlate with protection against East Coast fever.Deletion of the ORF2 gene of the neuropathogenic equine herpesvirus type 1 strain Ab4 reduces virulence while maintaining strong immunogenicity
P2860
Q34510602-1B5F002D-B2DC-4ED2-A48D-9616AD71FBC6Q34587404-B727C9BD-7015-40B9-B5CE-51F4F7F2A48BQ35037390-74078760-1356-4610-BC59-A400E75A6A75Q35230993-AFC045B1-F371-428C-B8ED-62B9F3F1E0CAQ35551564-D6C6A58B-01D1-419A-8FEA-5AA728BDFB6DQ35909589-E244A33C-DDC0-4AF2-B445-0EA9B8EA354EQ36165324-DF899986-902C-47EE-95DA-E787CE081A10Q36211658-F3EF4E8B-9832-472A-A8D3-620BD7EAA33BQ37676195-9974ACE0-E5AA-4B93-A791-7964E7B474E0Q38137249-BD62693B-1780-4F45-8E44-73251CB21028Q38245481-320B8267-07BD-4B8D-98B8-BE78AABD282DQ38269153-6AAB51EB-131E-4065-8268-8C7BA2042F81Q38807872-FF42D9F7-C7D5-4211-B15D-7E8C02FA1C21Q39143224-1314073F-635A-4897-B4F0-1F4DDB1768D1Q39671246-B1488003-3B0F-4527-86CD-3ACF32A4A62AQ40081016-643F50C4-5236-4C72-8166-875423E18471Q40322994-E326C5EC-BC84-4E5C-A9F9-0B1C89041A3BQ40389854-B621E78E-5F1F-4D8B-9F03-72D295069BD1Q41664475-77F9ABD1-4402-4174-98FB-CD5EE582C351Q42668224-644F28F8-6DCC-47B4-9942-76F94FA2151AQ46504761-C790EFAD-801F-470E-B2BF-AF8F4D4BB177Q50075378-447B5D67-69B7-44A5-A2D3-4DF2F8DAF552Q57016879-641219E4-81D1-4D76-8118-5FC29A5661E8
P2860
The different effector function capabilities of the seven equine IgG subclasses have implications for vaccine strategies.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
The different effector functio ...... ations for vaccine strategies.
@en
type
label
The different effector functio ...... ations for vaccine strategies.
@en
prefLabel
The different effector functio ...... ations for vaccine strategies.
@en
P2093
P2860
P1433
P1476
The different effector functio ...... ations for vaccine strategies.
@en
P2093
Bettina Wagner
Jenny M Woof
Melanie J Lewis
P2860
P304
P356
10.1016/J.MOLIMM.2007.06.158
P577
2007-07-31T00:00:00Z